Modulation of survival in osteoblasts from postmenopausal women

Bone

Volumn 35, Issue 1, 2004, Pages 170-177

  Garcia Moreno C ^a   Catalan M P ^b   Ortiz, A ^b   Alvarez, L ^c   De La Piedra, C ^a,d  

^a Bone Pathophysiology Laboratory   (Spain)

^b Nephrology   (Spain)

^c Jimenez Diaz Foundation   (Spain)

^d Fund Jim?nez D?az   (Spain)

Author keywords

Apoptosis; Fas; Osteoblast; Postmenopausal osteoporosis; TNF

Indexed keywords

6 HYDROXY 2 (4 HYDROXYPHENYL) 3 [4 [2 (1 PYRROLIDINYL)ETHOXY]BENZOYL]BENZO[B]THIOPHENE; CYTOKINE; ESTRADIOL; ESTROGEN; FAS ANTIGEN; FAS LIGAND; MESSENGER RNA; RALOXIFENE; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL STRAIN; CELL SURFACE; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; OSTEOBLAST; OSTEOSARCOMA CELL; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PROTEIN EXPRESSION; REGULATORY MECHANISM;

AGED; ANTIGENS, CD95; APOPTOSIS; CELL SURVIVAL; CELLS, CULTURED; ESTRADIOL; ESTROGENS; FEMALE; HUMANS; MIDDLE AGED; OSTEOBLASTS; OSTEOPOROSIS, POSTMENOPAUSAL; POSTMENOPAUSE; PYRROLIDINES; RECEPTORS, TUMOR NECROSIS FACTOR; SELECTIVE ESTROGEN RECEPTOR MODULATORS; THIOPHENES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 2942715128     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2004.02.021     Document Type: Article

References (38)

1. Riggs B.L., Khosla S., Melton L.J. A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contribute to bone loss in aging men. J. Bone Miner. Res. 13:1998;763-773
2. Cauley J.A., Seeley D.G., Ensrud K., Ettinger B., Black D., Cummings S.R. Estrogen replacement therapy and fractures in older women. Study of osteoporotic fractures research group. Ann. Intern. Med. 122:1995;9-16
3. Rossouw J.E., Anderson G.L., Prentice R.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from women's health initiative randomized controlled trial. JAMA. 288:2002;321-333
4. Draper M.W. The role of selective estrogen receptor modulators (SERMs) in postmenopausal health. Ann. N. Y. Acad. Sci. 997:2003;373-377
5. Eriksen E.F. Normal and pathological remodeling of human trabecular bone: three-dimensional reconstruction of the remodeling sequence in normals and in metabolic bone disease. Endocrinol. Rev. 7:1986;379-408
6. Boyce BF, Xing L, Jilka RL, Bellido T, Weinstein, RS, Parfitt AM, et al. Apoptosis in bone cells. In: Bilezikian JP, Raisz LG, Rodan G. editors. Princ Bone Biol, second ed. San Diego: Academic Press; 2002; 151, 168.
7. Kousteni S., Chen J.R., Bellido T., Han L., Ali A.A., O'Brien C.A., et al. Reversal of bone loss in mice by nongenotropic signaling of sex steroids. Science. 298:2002;843-846
8. Tomkinson A., Reeve J., Shaw R.W., Noble B.S. The death of osteocytes via apoptosis accompanies estrogen withdrawal in human bone. J. Clin. Endocrinol. Metab. 82:1997;3128-3135
9. Gupta S. Tumor necrosis factor-alfa-induced apoptosis in T cells from aged humans: a role of TNFR-I and downstream signaling molecules. Exp. Gerontol. 37:2002;293-299
10. Kitajima I., Nakajima T., Imamura T., Takasaki I., Kawahara K., Okano T., et al. Induction of apoptosis in murine clonal osteoblasts expressed by human T-cell leukemia virus type I tax by NF-kappaB and TNF-alpha. J. Bone Miner. Res. 11:1996;200-210
11. Tsuboi M., Kawakami A., Nakashima T., Matsuoka N., Urayama S., Kawabe Y., et al. Tumor necrosis factor alpha and interleukin-1beta increase the Fas-mediated apoptosis of human osteoblasts. J. Lab. Clin. Med. 134:1999;222-231
12. Kawakami A., Eguchi K., Matsuoka N., Tsuboi M., Koji T., Urayama S., et al. Fas and Fas ligand interaction is necessary for human osteoblast apoptosis. J. Bone Miner. Res. 12:1997;1637-1646
13. Pfeilschifter J., Köditz R., Pfohl M., Schatz H. Changes in proinflammatory cytokine activity after menopause. Endocr. Rev. 23:2002;90-119
14. Cenci S., Weitzmann M.N., Roggia C., Namba N., Novack D., Woodring J., et al. Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alfa. J. Clin. Invest. 106:2000;1229-1237
15. Katavic V., Lukic I.K., Kovacic N., Grcevic D., Lorenzo J.A., Marusic A. Increased bone mass is a part of the generalized lymphoproliferative disorder phenotype in the mouse. J. Immunol. 170:2003;1540-1547
16. García-Moreno C., Méndez-Dávila C., de la Piedra C., Castro-Errecaborde N.A., Traba M.L. Human prostatic carcinoma cells produce an increase in the synthesis of interleukin-6 by human osteoblasts. Prostate. 50:2002;241-246
17. Halstead L.R., Scott M.J., Rifas L., Avioli L.V. Characterization of osteoblast-like cells from normal adult rat femoral trabecular bone. Calcif. Tissue Int. 50:1992;93-95
18. Ortiz A., Lorz C., Gonzalez-Cuadrado S., Garcia del Moral R., O'Valle F., Egido J. Cytokines and Fas regulate apoptosis in murine renal interstitial fibroblasts. J. Am. Soc. Nephrol. 8:1997;1845-1854
19. Lorz C., Ortiz A., Justo P., González-Cuadrado S., Duque N., Gómez-Guerrero C., et al. Proapoptotic Fas ligand is expressed by normal kidney tubular epithelium and injured glomeruli. J. Am. Soc. Nephrol. 11:2000;1266-1277
20. Catalán M.P., Reyero A., Egido J., Ortiz A. Acceleration of neutrophil apoptosis by glucose-containing peritoneal dialysis solutions: role of caspases. J. Am. Soc. Nephrol. 12:2001;2442-2449
21. Catalán M.P., Subira D., Reyero A., Selgas R., Ortiz-Gonzalez A., Egido J., et al. Regulation of apoptosis by lethal cytokines in human mesothelial cells. Kidney Int. 64:2003;321-330
22. Garcia-Ocaña A., Gomez-Casero E., Peñaranda C., Sarasa J.L., Esbrit P. Cyclosporine increases renal parathyroid hormone-related protein expression in vivo in the rat. Transplantation. 65:1998;860-863
23. Ortiz A. Apoptotic regulatory proteins in renal injury. Kidney Int. 58:2000;467-485
24. Pacific R., Rifas L., McCracken R., Vered I., McMurtry C., Avioli L.V., et al. Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release. Proc. Natl. Acad. Sci. U. S. A. 86:1989;2398-2402
25. Pacifici R., Brown C., Puscheck E., Friedrich E., Slatopolsky E., Maggio D., et al. Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. Proc. Natl. Acad. Sci. U. S. A. 88:1991;5134-5138
26. Kitajima I., Soejima Y., Takasaki I., Beppu H., Tokioka T., Maruyama I. Ceramide-induced nuclear translocation of NF-kappaB is a potential mediator of the apoptotic response to TNF-alpha in murine clonal osteoblasts. Bone. 19:1996;263-270
27. Lajeunesse D. Effect of 17beta-estradiol on the human osteosarcoma cell line MG-63. Bone Miner. 24:1994;1-16
28. Sur P., Sribnick E.A., Wingrave J.M., Nowak M.W., Ray S.K., Banik N.L. Estrogen attenuates oxidative stress-induced apoptosis in C6 glial cells. Brain Res. 971:2003;178-188
29. Hatakeyama S., Tomiuchi N., Ohara-Nemoto Y., Satoh M. The immunohistochemical localization of Fas and Fas ligand in jaw bone and tooth germ of human fetuses. Calcif. Tissue Int. 66:2000;330-337
30. Ozeki N., Mogi M., Nakamura H., Togari A. Differential expression of the Fas-Fas ligand system on cytokine-induced apoptotic cell death in mouse osteoblastic cells. Arch. Oral Biol. 47:2002;511-517
31. Mor G., Sapi E., Abrahams V.M., Rutherford T., Song J., Hao X.Y., et al. Interaction of the estrogen receptors with the Fas ligand promoter in human monocytes. J. Immunol. 170:2003;114-122
32. Bellgrau D., Gold D., Selawry H., Moore J., Franzusoff A., Duke R.C. A role for CD95 ligand in preventing graft rejection. Nature. 377:1995;630-632
33. Griffth T.S., Brunner T., Fletcher S.M., Green D.R., Ferguson T.A. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science. 270:1995;1189-1192
34. Sata M., Walsh K. TNF alpha regulation of Fas ligand expression on the vascular endothelium modulates leukocyte extravasation. Nat. Med. 4:1998;415-420
35. Suda T., Okazaki T., Naito Y., Yokota T., Arai N., Ozaki S., et al. Expression of the Fas ligand in cells of T cell lineage. J. Immunol. 154:1995;3806-3813
36. Arase H., Arase N., Saito T. Fas-mediated cytotoxicity by freshly isolated natural killer cells. J. Exp. Med. 181:1995;1235-1238
37. Hahne M., Renno T., Schroeter M., Irmler M., French L., Bornand T., et al. Activated B cells express functional Fas ligand. Eur. J. Immunol. 26:1996;721-724
38. Fromigue O., Kheddoumi N., Lomri A., Marie P.J., Body J.J. Breast cancer cells release factors that induced apoptosis in human bone marrow stromal cells. J. Bone Miner. Res. 16:2001;1600-1610